Strata Critical Medical, Inc.

NASDAQ:SRTA

Airlines, Airports & Air Services

Industrials
$4.96 -0.43%

-$0.03 today

Market cap
$443.03M
Beta
2.20
P/E (TTM)
9.7
EPS (TTM)
$0.60
52W Low $3.57High $6.50

Volume 0.99M

Average 0.91M

SRTA Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Strata Critical Medical, Inc.NASDAQ: SRTA

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables turns positive

Q1 FY2026 accounts receivables was $149K, compared with -$520K a year earlier. Trailing-twelve-month accounts receivables was -$11.37M. Over 3 fiscal years it compounded at +31.0% a year.

Context

  • Accounts receivables amounted to 6.1% of revenue in FY2025, up 5.7 pp from a year earlier.
  • Accounts receivables grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts receivables holds near $149K or moves back toward the trailing-twelve-month quarterly average of -$2.84M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$149K+104.3% QoQ
Last fiscal yearDec 2025
-$12.03M+1105.8% YoY
LTMMar 2026
-$11.37M-1141.7% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+128.7%——
1 year+1105.8%——
3-year CAGR+31.0%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(12.03M) USD
Year-over-year change
-1105.8%

Accounts Receivables vs competitors

How SRTA compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -1141.7% is the lowest of 9, against a peer median of +47.0%.
  • Accounts receivables amounts to 4.5% of revenue for SRTA, versus a peer median of 1.0%.
SRTA Competitors
Accounts Receivables for SRTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MTRXMatrix Service CompanyLTM Mar 2026$37.61M USD+160.9%+29.5%4.4%
ULHUniversal Logistics Holdings, Inc.LTM Apr 2026$22.34M USD+114.9%—1.4%
KFRCKforce Inc.LTM Mar 2026$13.27M USD-18.0%—1.0%
CYRXCryoport, Inc.LTM Mar 2026$13.04M USD+242.4%+16.4%7.1%
SRTAStrata Critical Medical, Inc.LTM Mar 2026$11.37M USD-1141.7%+31.0%4.5%
EVTLVertical Aerospace Ltd.LTM Mar 2026£7.62M GBP———
AIROAIRO Group Holdings, Inc. Common StockLTM Mar 2026$5.69M USD—+321.9%6.5%
ORNOrion Group Holdings, Inc.LTM Mar 2026$4.92M USD+112.0%-9.4%0.6%
FLYXflyExclusive, Inc.LTM Mar 2026$2.87M USD-35.1%-33.1%0.7%
EBFEnnis, Inc.LTM Feb 2026$1.09M USD-88.6%—0.3%
ZIPZipRecruiter, Inc.LTM Mar 2026$257K USD-153.2%-20.5%0.1%
Peer median (excluding SRTA) —+47.0%+3.5%1.0%

Competitors are the stored peer set for SRTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Sep 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(40.05M)(27.26M)(56.08M)(27.31M)41.35M
Depreciation & Amortization596K5.73M7.11M5.96M8.19M
Deferred Income Tax(3.64M)(772K)(1.47M)(255K)432K
Stock-Based Compensation9.62M8.28M12.5M19.89M17.83M
Change in Working Capital(2.2M)(17K)(6.74M)(3.01M)(9.08M)
Accounts Receivables(414K)(5.35M)(10.25M)(998K)(12.03M)
Inventory00000
Accounts Payables09.9M000
Other Working Capital(1.79M)(4.57M)3.52M(2.01M)2.95M
Other Non-Cash Items20.06M(23.08M)12.32M2.2M(107.63M)
Operating Cash Flow(15.62M)(37.13M)(32.35M)(2.52M)(48.91M)
Capital Expenditures(801K)(730K)(2.11M)(32.99M)(11.01M)
Acquisitions (Net)(23.07M)(48.1M)(39K)(2.23M)(69.35M)
Purchases of Investments(308.77M)(228.21M)(265.97M)(143.26M)(146.26M)
Sales of Investments11.3M356.38M285.07M177.45M296.36M
Other Investing Activities(504K)0138K(2.11M)(1.42M)
Investing Cash Flow(321.34M)79.34M17.09M(1.02M)69.75M
Debt Repayment(1.17M)0000
Common Stock Issued119.63M87K00193K
Common Stock Repurchased000(244K)0
Dividends Paid00000
Other Financing Activities213.79M(1.17M)(76K)(5.52M)(9.11M)
Financing Cash Flow332.26M(1.08M)(76K)(5.76M)(8.91M)
Effect of Forex Changes10.97M(4.29M)(66K)(80K)(339K)
Net Change in Cash(4.69M)36.84M(15.4M)(9.37M)11.59M
Free Cash Flow(16.42M)(37.86M)(34.46M)(35.51M)(59.92M)

Strata Critical Medical, Inc.

NASDAQ:SRTA

Intrinsic Alpha fair value

Locked

Current Price

$4.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.